The best wrist braces for carpal tunnel syndrome of 2025, according to hand specialists and health experts
Pain, discomfort and numbness in your fingers can make everyday tasks like pushing a shopping cart or pulling the garbage can to the curb incredibly painful. And while hand and wrist pain can arise from any number of causes, a common culprit is carpal tunnel syndrome. CTS is a neurological condition that occurs when there's compression of the median nerve — one of the three major nerves of the forearm and hand. Pressure on that nerve often results in a tingling sensation, pain and numbness that can make living everyday life more challenging. While it's important to see a health care provider for wrist pain or numbness, one of the most common treatments for mild-to-moderate CTS is bracing. Dr. Raymond Hwang, vice president and medical director at Lantern, says, "Braces help keep the wrist in a neutral, slightly extended position, which relieves pressure on the median nerve as it travels through the carpal tunnel in the wrist. This can reduce numbness, tingling and pain."Certified hand therapist Brenda Cummings says, "Wrist braces for carpal tunnel work by keeping your wrist in a neutral position to alleviate pressure from the median nerve." To be effective, Cummings says, a brace should prevent you from being able to bend your wrist more than 15 degrees in any direction.To help find the best wrist braces for CTS, we spoke with orthopedic experts to learn what to look for in carpal tunnel-specific braces, and what to avoid. We learned that a rigid insert or stay (typically made of metal) is key to stabilizing the wrist. These stays may be found on the back of the wrist, the palm of the hand or on both sides. A dorsal support brace (those with stays on the back of the wrist) is often best for CTS since it prevents flexion, but depending on your level of pain or discomfort, a simple wrist brace or wrist wrap worn while sleeping may be the better choice.Using our experts' feedback, we evaluated more than 20 wrist braces for CTS, rating each based on construction, materials used, breathability, brand reputation, user and in-house tester reviews, cost, comfort and efficacy. These are the eight wrist braces for carpal tunnel that made our cut.
Update, June 25, 2025: We checked all product prices and availability. Our No. 1 pick for the best wrist brace for carpal tunnel remains unchanged.
Three stages categorize the symptoms and level of severity of carpal tunnel syndrome.
Stage 1: Frequently waking in the night with a sensation of a swollen, numb hand or severe pain that radiates from the wrist to the shoulder. There is also tingling in the hand and fingers. After waking, hand stiffness usually persists.
Stage 2: The symptoms are present during the day, especially if you stay in the same position for prolonged periods or perform repeated movements or tasks with the hand and wrist. This is the stage where you may have lost so much feeling in your hands and fingers that you frequently drop things.
Stage 3: This is the final stage where atrophy can set in and the median nerve may respond poorly even to more advanced treatments like surgical decompression. In this phase, sensory symptoms decline.
Comfortable fit: Carpal tunnel braces keep your wrist in a neutral position. Immobilization is important because wrist flexion puts pressure on the median nerve; bracing prevents this pressure. However, in order for the brace to work, it needs to fit correctly. It should be snug enough to provide adequate support, but not so tight that it restricts circulation or causes skin irritation.
Material: A big part of comfort has to do with quality materials. Neoprene is one of the best material choices since it offers compression, warmth, elasticity and breathability. Mesh fabric can also add to a brace's overall breathability. Softer materials, like memory foam, can provide padding for additional comfort. Some braces use copper-infused fabrics, which can help deodorize the brace. Most of these wrist braces are not machine-washable, but you can hand-wash some of them.
Structure and design: Most braces have a rigid insert on either the dorsal side (i.e., the back of the wrist), the palmar side, or both. Small studies indicate a dorsal support brace may be best for carpal tunnel since it prevents flexion without adding more pressure to the median nerve. Palmar support can be beneficial, too; just make sure that the rigid stays don't press in on the median nerve or that they're removable.
Length is also important. "A wrist brace that is too short may apply more pressure to the median nerve," says Cummings. Look for a wrist brace that doesn't stop directly at the wrist and instead extends about halfway up the forearm.
Cost: Finally, cost is something to consider. The best wrist brace for you is one that is comfortable and effective, but more expensive doesn't necessarily mean better.
To determine the best carpal tunnel braces, our team looked at over 20 different wrist braces and evaluated each based on their efficacy. The truth is, there are many wrist braces on the market, but not all of them work well to alleviate the specific symptoms of carpal tunnel syndrome. We considered factors like the overall structure and design of the brace, the amount of stability it provides and how comfortable it is to wear. Finally, we consulted two orthopedic experts, including a hand pain specialist and an orthopedic surgeon to get their input on which braces are the best options for CTS.
Dr. John Thomas, a board-certified hand surgeon, says that wrist braces can be extremely beneficial for mild to moderate carpal tunnel, especially when used overnight. "Most people like to curl up and fully flex their wrists at night," he says. "This places pressure upon the median nerve in the carpal tunnel and increases symptoms."
In addition to bracing, treatments for CTS include oral anti-inflammatory medication, steroid injections and, in severe cases, surgery to decompress the carpal tunnel and increase space for the median nerve.
You shouldn't consider wrist braces as a permanent fixture in your life. Instead, Thomas says, they're best worn for a few weeks. If symptoms don't improve, it's a sign you might need to try a more intensive form of treatment. Dr. Melissa Boyette, an orthopedic surgeon, says, "I would caution against wearing a brace longer than a few weeks if a physician has not evaluated you." She warns that prolonged bracing can lead to stiffness and weakness in the forearms and wrists.
Hwang recommends taking frequent hand/wrist stretching breaks, especially for those with repetitive hand motions at work. He also says, "Prevention through ergonomic workstations, exercises, and avoiding excessive wrist bending is important for those at risk." You can also try oral anti-inflammatory medication or a pain-relieving cream for immediate relief.
Dr. Melissa Boyette, orthopedic surgeon; hand and wrist specialist, Bradenton, Fla.
Brenda Cummings, OTD, OTR, CHT, certified hand therapist, Fort Collins, Colo.
Dr. Raymond Hwang, orthopedic surgeon and medical director at Hinge Health
Dr. John Thomas, orthopedic hand surgeon, New York City
Our health content is for informational purposes only and is not intended as professional medical advice. Consult a medical professional on questions about your health.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
42 minutes ago
- CBS News
Greene County woman with cancer says she's concerned about Medicaid cuts
In Greene County, Brittanny Groover is fighting two major battles right now: stage three melanoma and keeping her Medicaid. "I have better days, I have worse days. Right now, I'm actually kind of in the worst slump that I've been in my entire treatment," she said. According to the White House, the Trump administration's budget bill includes tax cuts, higher wages and border security, but it also features major cuts to Medicaid, a program that helps low-income families and individuals. "We're very concerned that they're proposing over $700 billion in cuts to that program," said Donna Greco, the government relations director for the American Cancer Society's Cancer Action Network. It's a non-profit to help people impacted by cancer and provide affordable health care. She says they're working with people like Groover to send a message. "We encourage community members throughout the state to talk to their lawmakers and urge them to vote no on any cuts to Medicaid," said Greco. "That's the only way to make a difference, is to use our voices," said Groover. They want to remove the idea that people who are on Medicaid don't work. In fact, the bill includes new work requirements for adults who have Medicaid. "Health is wealth. I say this all the time. In order to be able to work, you have to have your health. And to be able to have your health, you have to have health insurance, especially if you have cancer," said Groover. According to the Congressional Budget Office, the proposed cuts to Medicaid would cause more than 7.5 million people to lose their health insurance in the next 10 years. KDKA-TV reached out to Congressman Guy Reschenthaler, whose district includes Greene County, where Brittanny lives. He was unable to do an interview, but referred KDKA-TV to his statement on the bill, which he voted for. It reads in part, "I am proud to support landmark legislation which fulfills this once-in-a-generation opportunity to deliver the largest tax cut for the working class." Right now, the bill is in the Senate, and they want to vote on it this week. If it passes, the bill will then have to go back to the House to be completed. Republicans are hoping it will land on President Trump's desk by July 4.


CNN
an hour ago
- CNN
New CDC vaccine advisers endorse thimerosal-free flu vaccines, despite no evidence of harm from the preservative
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that Americans receive influenza vaccines that are free of thimerosal even though there is no evidence of harm from the preservative. The closely watched vote was among the first for the newly assembled group, which was appointed by US Health and Human Services Secretary Robert F. Kennedy Jr. this month after he dismissed the previous panel of 17 experts, claiming that they had conflicts of interest. However, some of the new members of the committee raised serious concerns from the public health community for their approach to vaccines and scientific evidence. The last-minute addition of thimerosal to the Advisory Committee on Immunization Practices' meeting agenda was a signal to vaccine experts that Kennedy – who led an anti-vaccine group called Children's Health Defense – was seeking to sow doubt about vaccine safety. Thimerosal was largely removed from most vaccines about 25 years ago. The US Food and Drug Administration asked manufacturers to remove it out of an abundance of caution, not because of evidence of harm, according to the CDC. All vaccines routinely recommended for young children now are available in doses that don't have the preservative, which contains a form of mercury. Flu vaccines drawn from multidose vials still contain thimerosal in order to prevent bacterial contamination. Only about 4% of flu vaccines given in the United States last year contained thimerosal as a preservative. Still, on Thursday, the committee heard an unusual presentation by Lyn Redwood, a nurse practitioner and former leader of Children's Health Defense, which has advocated against the use of mercury in vaccines. Unlike most other presentations given at the meeting, Redwood's was not vetted or read by a working group or outside experts in vaccine science before it was voted on, according to Dr. Sean O'Leary, a pediatrician at Children's Hospital of Colorado who has been a liaison member of the Advisory Committee on Immunization Practices, or ACIP. 'This selective use of data and omission of established science undermines public trust and fuels misinformation,' O'Leary said in a statement made on behalf of the American Academy of Pediatrics, which recently announced that it would no longer participate in ACIP meetings because of the changes to committee membership and what's being discussed. In a series of three votes Thursday, the ACIP members voted 5-1, with one member abstaining, to recommend that only single-dose flu vaccines be given to children, adults and pregnant women in the United States. Single-dose shots are free of thimerosal. Drs. Robert Malone, Joseph Hibbeln, Martin Kulldorff, Retsef Levi and Joseph Pagano voted yes on the thimerosal recommendations. Dr. Cody Meissner voted no. Dr. Vicky Pebsworth, volunteer director of research and patient safety at the National Vaccine Information Center, a group that emphasizes risks around vaccines while downplaying their benefit, abstained from the vote because she objected to its wording. In justifying his vote, Meissner, a professor of pediatrics at the Dartmouth Geisel School of Medicine, said he was worried that expressing a preference for single-dose vials might keep people from getting doses from multidose formulations in situations in which those shots may be the only option. 'That might limit the availability of the influenza vaccine for some people,' he said. 'My point is, the risk from influenza is so much greater than the nonexistent — as far as we know — risk from thimerosal, so I would hate for a person not to receive the influenza vaccine,' Meissner said. 'I find that very hard to justify.' Six members of the committee voted to continue to recommend that everyone 6 months and older receive an annual flu vaccine. Pebsworth abstained. Vaccines with thimerosal are still approved by the FDA. The ACIP recommendation now goes to the CDC director or potentially to Kennedy, as CDC nominee Dr. Susan Monarez is still awaiting Senate confirmation. However, ACIP recommendations are tremendously influential in how vaccines are used in the US, with implications for insurance coverage and state policies. The advisers also voted 5-2 on Thursday to recommend the use of a new shot that can protect babies from respiratory syncytial virus, adding an additional tool against the most common cause of hospitalization in infants. The shot, called clesrovimab and given the brand name Enflonsia, is made by Merck and joins two other interventions already on the market to protect babies against severe disease from RSV, a common virus that can be especially dangerous for infants. One, like clesrovimab, is an antibody shot, and the other is a vaccine given during pregnancy. Data presented at the meeting showed that the approved interventions were safe and dramatically reduced hospitalizations among babies from RSV in the last respiratory virus season. 'As a pediatrician, I mean, people need to understand what a spectacular accomplishment these results are,' Meissner said at Wednesday's ACIP meeting. They 'will have an enormous influence on public health.' The new drug was approved this month by the FDA, and the CDC committee's recommendation was the next step in making it widely available for the coming RSV season, which typically begins in the fall. The vote came after Levi, a professor of operations management at the Massachusetts Institute of Technology Sloan School of Management, raised questions Thursday morning about whether there were safety signals that arose in clinical trials of the antibody shots that deserve further scrutiny. Representatives from both the FDA and Merck emphasized the safety of the product and the rigor of the clinical trials. Meissner also expressed how thoroughly the CDC panel's work group on RSV examined the data. 'We went through the details very, very carefully, and I appreciate Dr. [Levi's] careful review of the records, but the work group is comfortable with the results from the different clesrovimab trials,' he said. Levi voted against recommending the Merck shot, joined by Pebsworth. However, the group voted unanimously Thursday that the Merck shot should be included in the Vaccines for Children program, which provides free vaccines to children whose families may not be able to afford them. HHS spokesperson Andrew Nixon said in a statement Thursday, 'The members of this committee are respected experts who take their responsibility to public health seriously. What they did today, just as Secretary Kennedy appointed them to do was review the evidence, debate it with scientific rigor and deliver recommendations rooted in data and medical integrity. The public deserves nothing but this.'


Fox News
an hour ago
- Fox News
Heart attack deaths have plummeted in US, but new cardiovascular threats emerge
Print Close By Melissa Rudy Published June 26, 2025 Heart attack deaths have plummeted in recent years — but other types of cardiovascular disease still pose a major threat. A new study by the American Heart Association (AHA) found that overall heart disease-related death rates have declined by 66%, and heart attack deaths have dropped by almost 90%. While heart attacks are no longer the most fatal form of heart disease, there have been increases in other types — heart failure, arrhythmias (irregular heartbeats) and hypertensive heart disease (long-term high blood pressure). CANNABIS USE RAISES RISK OF HEART ATTACK AND STROKE MORE THAN COCAINE, OTHER DRUGS, MAJOR REVIEW SUGGESTS The findings were published in the peer-reviewed Journal of the American Heart Association. In the study, researchers analyzed more than 50 years of data from the U.S. Centers for Disease Control and Prevention (CDC), focusing on heart disease deaths among adults aged 25 and older. In 1970, heart attacks — also known as ischemic heart disease — represented more than half (54%) of all heart disease deaths, the study found. As of 2022, only 29% of heart disease deaths were caused by heart attacks. Other types of heart disease deaths — such as heart failure, hypertensive heart disease and arrhythmia — have risen during that timeframe, however. EXPERIMENTAL CHOLESTEROL PILL CUTS HEART ATTACK RISK WITH 'CONVENIENT' ONCE-DAILY DOSE In 2022, these other types were responsible for 47% of heart disease deaths, up from just 9% in 1970, the study found. "This distribution shift in the types of heart disease people were dying from the most was very interesting to us," said the study's first author, Sara King, M.D., a second-year internal medicine resident in the department of medicine at Stanford School of Medicine in Stanford, California, in the release. "This evolution over the past 50 years reflects incredible successes in the way heart attacks and other types of ischemic heart disease are managed," she went on. "However, the substantial increase in deaths from other types of heart conditions, including heart failure and arrhythmias, poses emerging challenges the medical community must address." "The increase in other types of heart disease leading to death has offset the wins from deaths from heart attacks declining." Arrhythmias, or irregular heartbeats, happen when electrical impulses to the heart are too fast, slow or erratic, according to the AHA. One common example of an arrhythmia is atrial fibrillation (AFib), which begins in the upper chambers of the heart. Heart failure is defined as a "chronic condition where the heart is unable to pump enough blood to meet the body's needs for blood and oxygen." Hypertensive heart disease describes damage to the heart caused by long-term, unaddressed high blood pressure, the AHA stated. Sadiya S. Khan, MD, a cardiologist and associate professor at Northwestern University in Chicago, was not involved in the study but commented on the "important analysis." "Fortunately, this study suggests important progress in a preventable cause of death — heart attacks," she told Fox News Digital. STANFORD RESEARCHERS DEVELOP 'GAME-CHANGING' STROKE TREATMENT THAT DOUBLES EFFECTIVENESS "Unfortunately, it suggests that there is a smoldering crisis of other types of heart disease deaths that may be in part related to heart attacks, but speak to the growing burden of obesity that results in more heart failure and arrhythmia-related deaths." "The increase in other types of heart disease leading to death has offset the wins from deaths from heart attacks declining." Why the decrease in heart attacks? The researchers presented several possible reasons for the decrease in heart attack deaths, primarily advancements in treatment for sudden and acute cardiac events. "From the establishment and increased use of bystander CPR and automated external defibrillators (AEDs) to treat cardiac arrest outside the hospital setting, to the creation of systems of care that promote early recognition of and quick procedural and medical intervention to treat heart attacks, there have been great strides made in helping people survive initial acute cardiac events that were once considered a death sentence," King said in the release. The researchers also touted several other medical advancements, including coronary artery bypass grafting, cardiac imaging and many new heart disease medications. Healthy lifestyle modifications, such as quitting smoking, exercising regularly and managing cholesterol and blood pressure, have also contributed to the reduced heart attack deaths, the AHA report stated. Khan added, "It is important to note that this doesn't mean the heart attack may still not have been the driver, if someone with a heart attack developed heart failure and that is now called a heart failure death." Risk factors remain Despite the improvements, the researchers cautioned that several other heart disease risk factors — including obesity, type 2 diabetes, hypertension and physical inactivity — are still fueling cases. Obesity in particular has risen from 15% to 40% during the study timeframe, and type 2 diabetes affects nearly half of U.S. adults, according to the report. Increased life expectancy is another factor — as people are living longer, a larger aging population is more likely to experience various types of heart disease. CLICK HERE TO GET THE FOX NEWS APP "We've won major battles against heart attacks; however, the war against heart disease isn't over," King said. "We now need to tackle heart failure and other chronic conditions that affect people as they age." "The next frontier in heart health must focus on preventing heart attacks, and also on helping people age with healthier hearts and avoiding chronic heart conditions later in life." The AHA calculates heart health based on an individual's score for what it calls "Life's Essential 8." Those who score high in those eight areas are, on average, six years younger biologically than their actual age. CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER The eight lifestyle behaviors for optimal heart health are listed below. Eat better Be more active Quit tobacco Get healthy sleep Manage weight Control cholesterol Manage blood sugar Manage blood pressure Potential limitations The researchers pointed out several limitations of their study, including that they did not analyze data by age, sex, race, ethnicity, region or urbanization. There could also be potential inconsistencies and "miscoding" of data over the years, they noted. "We've won major battles against heart attacks; however, the war against heart disease isn't over." It's also possible that the "true burden" of heart attacks is "underestimated" in the findings, according to the researchers. "Certain conditions including heart failure, cardiomyopathy and arrhythmias — and, in particular, ventricular arrhythmias and cardiac arrest — may be overly simplistic," they wrote. "Many of these cases likely have underlying causes that cannot be precisely differentiated using current or past ICD (International Classification of Diseases) codes." For more Health articles, visit Khan pointed out that despite the decrease in direct heart attack deaths, heart disease overall is still the leading cause of mortality in the U.S., accounting for more than 900,000 deaths in 2022. Print Close URL